Within3

The integrated insights solution for pharmaceutical companies.

[Within3 @Within3]

Missed Episode 1 of The Summit Series: Launch Leadership?

What we heard from your peers:
• 33% of teams act with true agility mid-launch
• 16% say decisions are consistently executed

Watch the replay 👇
https://t.co/7AI7KAn09K

[Within3 @Within3]

What were the biggest takeaways from @MAPSmedaffairs Americas Annual Meeting?

Across sessions and conversations with Medical Affairs leaders, a few themes stood out.

👇 Read the State of Medical Affairs: MAPS 2026 Key Takeaways

https://t.co/ipX4WZD5HO

[Within3 @Within3]

AI is multiplying signals across pharma launches.
Yet decisions still stall.

Unclear ownership.
Shifting evidence thresholds.
Medical + commercial misalignment.

Join your peers and pharma leaders for The Summit Series: Launch Leadership.

https://t.co/aZ38VBA1RD

[Within3 @Within3]

How much revenue is slow decision-making costing your launch?

In #pharma, a few weeks of delay can erode launch momentum — and millions in revenue.

Our new eBook explores the real cost of slow. 👇
https://t.co/iDFJIQYBwi

#PharmaLaunch #LaunchExcellence

[Within3 @Within3]

Is confirmation bias impacting your launch strategy?

Even the most experienced #Pharma leaders aren’t immune. Discover how it can shape critical launch decisions—and what to do about it.

https://t.co/cv9yXzAQpx

#LaunchExcellence #LifeSciences

[Within3 @Within3]

@Within3 is heading to MAPS Americas in Denver! 🏔️

Come find us at booth 109 and explore how real-time Launch Intelligence is empowering #MedicalAffairs leaders to make confident, timely decisions.

📍 Stop by booth 109

https://t.co/zFmL9amMfl

#MedicalAffairs #MAPS

[Within3 @Within3]

Within3 announces #Dataverse — an invite-only ecosystem of data & insight partners powering Launch Intelligence™.

Unifying RWE, EHR, claims & specialty data in a governed environment for faster, smarter launches. Learn more: https://t.co/YTeQ9gsW5H

#LaunchIntelligence

[Within3 @Within3]

#LaunchExcellence needs real-time insights, aligned teams, and adaptive strategy.

Discover the 3 biggest launch hurdles and how to overcome them 👇
https://t.co/1fZo0Mku29

#PharmaLaunch #MedicalAffairs #LifeSciences

[Within3 @Within3]

Markets don’t wait for launch plans to catch up.

Leading #LifeSciences teams are redefining #LaunchExcellence as a continuous feedback loop—refining strategy before, during, and after launch.

Learn more 👇
🔗 https://t.co/S7gcedK2cA

[Within3 @Within3]

AI is changing the pace of #pharma launches.

See how to turn months of reporting into days with #AI purpose-built for pharma.

https://t.co/Br5Y4VExsq

#PharmaLaunch #LaunchExcellence #LifeSciences #Data

[Within3 @Within3]

High-stakes launch? Real-time Launch Intelligence™ helped uncover an overlooked prescriber segment mental health professionals—so the team could pivot fast, protect investment, and accelerate patient access.

Read the case study: https://t.co/R7aZ3OpKht

#AI #LaunchExcellence

[Within3 @Within3]

Within3 is proud to sponsor Momentum Events 5th Annual AI in Medical Affairs Conference next week!

Don’t miss Jason Smith, CTO of AI & Analytics at Within3, exploring the impact of AI-driven decision-making—and how MA teams must adapt as HCPs increasingly rely on AI tools.

[Within3 @Within3]

Influence in #LifeSciences is shifting beyond traditional KOLs. Patients, caregivers, and digital advocates are now shaping real-world decisions

Explore why launch teams must listen to emerging digital voices:
https://t.co/R137CPei9O

#PharmaLaunch

[Within3 @Within3]

It’s reasonable to feel cautious about #AI — especially in #LifeSciences.

Here’s why the human side of AI is essential for keeping innovation safe, ethical, and effective.

👉 Explore our latest blog post:
https://t.co/3ddK3fwtMs

#MedicalAffairs #Pharma #ResponsibleAI

[Within3 @Within3]

In 2026, #AI won’t just support #pharma launches — it will shape who succeeds.

We identified five AI trends set to define the next era of launch — from predictive sentiment insight to real-time market response.

Read the 2026 predictions ⬇️
https://t.co/GAXvHyqDI7

[Within3 @Within3]

We asked. You answered.

Based on expert input and industry leader survey data, @Within3 has compiled the #AI trends set to define #pharma in 2026—from insight automation to real-time launch strategy.

Read all 9 predictions 👇
https://t.co/QuD2RYlm38

[Within3 @Within3]

Missed the #Pharma Launch Excellence Summit in London?

Here’s what top launch leaders say will define success in 2026 — the 5 themes shaping pharma’s next era of #LaunchExcellence.
👉 https://t.co/KLYVuJhtnX

[Within3 @Within3]

What’s real vs. hype in AI for #MedicalAffairs?

Join MAPS to dive into practical AI for launch readiness + cross-functional impact.

Sign up: https://t.co/Iwvxakj8My

#pharma #launchexcellence #Webinar

[Within3 @Within3]

What really haunts #pharma launches?

In our Halloween webinar, Good Omens and Bad Launches, Paul Simms (Impatient Health) and Ian McKinnon (Within3) unpacked how early signals can make or break a launch.

🎥 Catch the replay: https://t.co/BNNnfVw3to

[Within3 @Within3]

AI is already changing how #pharma teams plan, launch, and adapt, but where will it make the biggest impact next year?

Add your voice to The 2026 Predictions Report: What’s Next for AI in Pharma.

Share your perspective: https://t.co/JNLDftlZ01

#lifesciences #ai